1174
G. Hua et al.
LETTER
JP–Se = 340 Hz), 386.5 (d, JP–Se = 357 Hz), –177.8 (d, JP=Se
789 Hz), –191.1 (d, JP=Se = 803 Hz). MS (CI+): m/z = 493
=
3:4:2:2 extensity ratio. IR (KBr): 1657 (s, C=C), 1432 (s),
1226 (m), 1089 (s), 819 (m), 699(vs), 595 (m), 507 (s) cm–1.
1H NMR (CD2Cl2): d = 8.22–7.01 (m, 4 × 9 H, thienyl-H +
ArH), 6.65–6.94 (m, 4 × 2 H, thienyl-H), 5.65–5.75 (m, 4 ×
1 H, =CH), 3.29–3.29 (m, 4 × 1 H, SeCH). 13C NMR
(CD2Cl2): d = 144.2, 143.8, 143.6, 143.2, 138.9, 136.1,
135.2, 134.6, 133.7, 133.6, 133.0, 132.9, 132.7, 132.5,
132.4, 132.1, 131.7, 128.8, 128.3, 128.2, 128.0, 127.9,
127.3, 126.9, 125.2, 125.1, 123.7, 123.5, 44.5, 43.8, 43.3,
[M + H]+. MS (EI+) m/z = 492 [M]+. HRMS (EI+): m/z [M]+
calcd for C22H18FP76Se2: 483.9509; found: 483.9504.
Compound 5: yellow solid (403 mg) in 83% isolated yield.
Two stereoisomers were found in ca. 1:2 intensity ratio. IR
(KBr): 1598 (w, C=C), 1491 (m, C=C), 1434 (m, C=C),
1185 (w), 1165 (w), 1128 (w), 1088 (s), 939 (s), 764 (s), 745
(s), 688(vs), 630 (m), 595 (s), 506 (s, P=Se) cm–1. 1H NMR
(CDCl3): d = 7.47–7.63 (m, 2 × 2 H, ArH), 7.30–7.37 (m, 2
× 5 H, ArH), 7.12–7.21 (m, 2 × 4 H, ArH), 7.04–7.11 (m, 2
× 4 H, ArH), 6.93–6.96 (m, 2 × 2 H, ArH), 7.05 (d, J = 3.0
Hz, 1 H, CH), 6.95 (d, J = 3.0 Hz, 1 H, CH), 6.66 (dd,
3JH,H = 3.0 Hz, 3JP,H = 15.0 Hz, 1 H, CH), 6.36 (dd,
3JH,H = 3.0 Hz, 2JP,H = 32.0 Hz, 1 H, CH). 13C NMR (CDCl3):
d = 141.0, 136.0, 135.8, 133.1, 133.0, 132.6, 132.4, 132.0,
129.0, 128.8, 128.3, 128.2, 127.9, 127.8, 127.0, 125.2, 70.3
(d, 1JP,C = 29 Hz). 31P NMR (CDCl3): d = 70.3 (s, JP–Se = 338
Hz, JP=Se = 803 Hz), 69.9 (s, JP–Se = 350 Hz, JP=Se = 782 Hz).
77Se NMR (CDCl3): d = 374.0 (d, JP–Se = 338 Hz), 354.9 (d,
JP–Se = 350 Hz), –170.7 (d, JP=Se = 782 Hz), –188.0 (d,
JP=Se = 803 Hz). MS (ES+): m/z = 507 [M + Na]+. Anal. Calcd
for C23H19PSe2 (484.29): C, 57.04; H, 3.95. Found: C, 57.01;
H, 3.99.
41.0. 31P NMR (CD2Cl2): d = 71.1 (s, JP–Se = 336 Hz, JP=Se
810 Hz), 69.1 (s, JP–Se = 341 Hz, JP=Se = 792 Hz), 61.0 (s,
=
JP–Se = 377 Hz, JP=Se = 789 Hz), 60.5 (s, JP–Se = 393 Hz, JP=Se
= 777 Hz). 77Se NMR (CD2Cl2): d = 477.2 (d, JP–Se = 377
Hz), 412.7 (d, JP–Se = 341 Hz), 407.3 (d, JP–Se = 336 Hz),
398.5 (d, JP–Se = 393 Hz), –142.5 (d, JP=Se = 777 Hz), –166.4
(d, JP=Se = 789 Hz), –176.7 (d, JP=Se = 792 Hz), –203.3 (d,
JP=Se = 810 Hz). MS (EI+): m/z = 472 [M]+. HRMS (EI+):
m/z [M]+ calcd for C17H13PS274Se2: 459.8640; found:
459.8635.
General Procedure for Synthesis of Compounds 9 and 10
from the Selenation of Aromatic a,b-Unsaturated Enals:
A red solution of aromatic enal (1.0 mmol) and WR (0.54 g,
1.0 mmol) in anhyd toluene (20 mL) was refluxed for 7 h.
Red suspension disappeared and a pale brown solution along
with small amount of grey elemental selenium precipitate
was formed. Upon cooling to r.t. the mixture was dried in
evaporator and the residue was purified by silica gel column
(eluent: EtOAc–CH2Cl2, 1:5) to give compounds 9 and 10.
Compound 9: reddish yellow paste (600 mg) in 79%
isolated yield. 31P NMR spectrum revealed a mixture of four
stereoisomers in ca. 5:7:5:3 intensity ratio. IR (KBr): 1673
(s, C=C), 1491 (m), 1450 (m), 1434 (m), 1121 (m), 1088
(m), 961 (m), 764(vs), 693(vs), 591 (m), 511 (m)cm–1. 1H
NMR (CD2Cl2): d = 7.92–8.11 (m, 2 H, ArH), 7.07–7.58 (m,
8 H, ArH), 6.84–6.96 (m, 1 H, CH), 6.58–6.66 (m, 1 H, CH),
6.11–6.16 (m, 1 H, CH). 13C NMR (CD2Cl2): d = 137.0,
136.7, 134.0, 133.5, 133.4, 132.4, 132.2, 132.0, 131.6,
130.7, 129.6, 129.5, 129.0, 128.9, 128.7, 128.6, 128.4,
128.2, 128.1, 127.9, 127.5, 126.6, 32.0. 31P NMR (CD2Cl2):
Compound 6: brown solid (340 mg) in 67% yield. 31P NMR
spectrum revealed four stereoisomers in ca. 4:2:1:2 intensity
ratio. IR (KBr): 1691 (m, C=C), 1594 (m, C=C), 1518 (s,
C=C), 1434 (m), 1343 (s), 1089 (m), 851 (s), 689 (s), 596
(m), 508 cm–1. 1H NMR (CD2Cl2): d = 7.54–8.30 (m, 4 × 10
H, thienyl-H, ArH), 7.00–7.32 (m, 2 H, thienyl-H), 6.75–
6.93 (m, 4 × 1 H, =CH), 3.26–3.44 (m, 4 × 1 H, SeCH).
13C NMR (CD2Cl2): d = 150.4, 148.0, 147.7, 147.3,
143.5,142.1, 141.2, 139.2, 133.1, 133.0, 132.9, 132.7, 132.5,
132.0, 131.8, 129.1, 128.9, 128.8, 128.7, 128.6, 128.3,
128.1, 127.9, 127.8, 127.4, 127.1, 125.0, 124.6, 124.2,
123.9, 123.6, 67.6, 67.1, 61.8, 61.4, 41.1, 23.9. 31P NMR
(CD2Cl2): d = 73.7 (s, JP–Se = 331 Hz, JP=Se = 832 Hz), 71.8
(s, JP–Se = 340 Hz, JP=Se = 796 Hz), 61.0 (s, JP–Se = 366 Hz,
JP=Se = 793 Hz), 54.1 (s, JP–Se = 380 Hz, JP=Se = 782 Hz). 77Se
NMR (CD2Cl2): d = 487.1 (d, JP–Se = 381 Hz), 473.1 (d, JP–Se
= 365 Hz), 414.8 (d, JP–Se = 329 Hz), 405.6 (d, JP–Se = 341
Hz), –83.2 (d, JP=Se = 782 Hz), –161.5 (d, JP=Se = 793 Hz),
–166.7 (d, JP=Se = 796 Hz), –190.8 (d, JP=Se = 832 Hz). MS
(EI+): m/z = 511 [M]+. HRMS (EI+): m/z [M]+ calcd for
C19H14O2NPS74Se2: 498.8927; found: 498.8933.
Compound 7: dark red solid (250 mg)in 50% yield.
31P NMR spectrum revealed two stereoisomers in ca. 3:1
intensity ratio. IR (KBr): 1634 (s, C=C), 1557 (m, C=C),
1539 (m, C=C), 1470 (s), 1435 (m), 1408 (m), 1220 (m),
1071 (m), 781 (m), 748 (m), 686 (s)cm–1. 1H NMR (CD2Cl2):
d = 6.96–8.15 (m, 2 × 9 H, ArH), 6.41 (d, JP,H = 16.5 Hz, 1
H, CH), 6.40 (d, JP,H =16.5 Hz, 1 H, CH), 3.77–4.04 (m, 2 ×
1 H, CH), 3.37 (s, 6 H, Me), 2.94 (s, 6 H, Me). 13C NMR
(CD2Cl2): d = 142.6, 140.5, 138.2, 134.8, 132.7, 132.5,
132.3, 132.0, 131.4, 131.2, 130.2, 130.0, 128.8, 128.6,
127.2, 126.1, 61.1, 56.6, 37.1, 34.1. 31P NMR (CD2Cl2): d =
57.0 (s, JP–Se = 333 Hz, JP=Se = 787 Hz), 56.1 (s, JP–Se = 369
Hz, JP=Se = 785 Hz). 77Se NMR (CD2Cl2): d = 455.2 (d, JP–Se
= 369 Hz), 450.0 (d, JP–Se = 333 Hz), –131.2 (d, JP=Se = 785
Hz), –131.6 (d, JP=Se = 787 Hz). MS (EI+): m/z = 505 [M]+.
HRMS (EI+): m/z [M]+ calcd for C17H17BrPSe2: 504.8612;
found: 504.8615.
d = 72.6 (s, JP–Se = 326 Hz, JP=Se = 802 Hz), 72.1 (s, JP–Se
=
336 Hz, JP=Se = 784 Hz), 55.6 (s, JP–Se = 383 Hz, JP=Se = 770
Hz), 55.5 (s, JP–Se = 383 Hz, JP=Se = 767 Hz). MS (CI+):
m/z = 385 [M + H]+. HRMS (CI+): m/z [M + H]+ calcd for
C15H14PSe2: 384.9160; found: 384.9159.
Compound 10: greyish yellow solid (230 mg) in 56%
isolated yield. 31P NMR spectrum revealed a pair of
stereoisomers in ca. 1:2 intensity ratio. IR (KBr): 1597 (m,
C=C), 1490 (s), 1460 (s), 1434 (m), 1244(vs), 1026 (m), 750
(s) cm–1. 1H NMR (CD2Cl2): d = 7.02–8.20 (m, 2 × 6 H,
thienyl-H + ArH), 6.83–6.99 (m, 2 × 3 H, thienyl-H), 6.37–
6.51 (m, 2 × 1 H, =CH), 5.38–5.44 (m, 2 × 1 H, PCH), 3.87
(s, 3 H, OMe), 3.80 (s, 3 H, OMe), 3.29–3.45 (m, 2 × 1 H,
SeCH). 13C NMR (CD2Cl2): d = 157.4, 156.5, 148.0, 146.0,
133.7, 133.6, 132.0, 131.9, 131.7, 131.5, 129.7, 129.4,
129.3, 129.2, 129.1, 128.5, 128.3, 128.0, 127.9, 127.4,
127.3, 127.2, 127.0, 58.1, 57.6, 55.6, 55.5. 31P NMR
(CD2Cl2): d = 71.9 (s, JP–Se = 322 Hz, JP=Se = 798 Hz), 75.1
(s, JP–Se = 315 Hz, JP=Se = 782 Hz). 77Se NMR (CD2Cl2): d =
410.8 (d, JP–Se = 322 Hz), 381.6 (d, JP–Se = 315 Hz), –91.4 (d,
JP=Se = 782 Hz), –183.8 (d, JP=Se = 798 Hz). MS (CI+): m/z =
415 [M + H]+. HRMS (CI+): m/z [M + H]+ calcd for
C16H16OPSe2: 414.9265; found: 414.9264.
Compound 8: pale yellow solid (224 mg) in 48% yield.
Multi-NMR spectrum revealed four stereoisomers in ca.
(25) Sheldrick, G. M. SHELXL97. Acta Crystallogr., Sect A
2008, A64, 112.
Synlett 2012, 23, 1170–1174
© Thieme Stuttgart · New York